Characterisation of the in vivo interactions between detomidine and methadone in horses: Pharmacokinetic and pharmacodynamic modelling.
Authors: Gozalo-Marcilla M, Luna S P L, Moreira da Silva R, Crosignani N, Lopes N P, Taylor P M, Pelligand L
Journal: Equine veterinary journal
Summary
# Editorial Summary Gozalo-Marcilla et al. (2019) conducted a rigorous pharmacokinetic and pharmacodynamic (PK/PD) modelling study to characterise how detomidine and methadone interact when used separately or in combination for standing sedation in horses. Eight healthy horses received six intravenous treatments (saline control, detomidine alone at 5 µg/kg, methadone alone at 0.2 mg/kg, and three combinations with detomidine doses of 2.5, 5 and 10 µg/kg) in a randomised crossover design, with plasma drug concentrations measured via LC-MS/MS and effects assessed across multiple parameters including head height, visual sedation scores, thermal and electrical pain thresholds, mechanical nociception and gastrointestinal motility. The research revealed complex, parameter-specific interactions: whilst detomidine reduced its own clearance and that of methadone, methadone produced partial antagonism of sedation and gastrointestinal effects (infra-additive) but synergistic potentiation of electrical and thermal analgesia and additive mechanical analgesia. For practitioners designing sedation protocols, these findings demonstrate that combining these agents will not simply produce predictable additive effects—sedation may be less profound than expected, yet pain thresholds (particularly to heat and electrical stimulation) may be enhanced beyond simple summation, warranting individualised dose titration and careful clinical monitoring rather than relying on standard combination dosing regimens.
Read the full abstract on PubMed
Practical Takeaways
- •Combined detomidine-methadone protocols show complex interactions that vary by outcome measured; sedation effects are reduced (partial antagonism) while some pain thresholds are enhanced, requiring careful dose adjustment in clinical practice
- •Detomidine reduces clearance of both itself and methadone, potentially leading to prolonged drug effects and warranting longer monitoring times when drugs are combined
- •These pharmacokinetic/pharmacodynamic models can be used to simulate constant rate infusion protocols for standing horse sedation/analgesia, improving protocol design for future clinical use
Key Findings
- •Detomidine follows a 2-compartment model while methadone follows a 3-compartment model in horses
- •Detomidine decreases its own clearance and the clearance of methadone, indicating significant pharmacokinetic interaction
- •Methadone produces infra-additive (partial antagonism) effects on detomidine-induced sedation (HHAG α = -1.33, VAS α = -0.98) and gastrointestinal motility
- •Methadone demonstrates positive potentiation for electrical (pot = 0.0041) and thermal (pot = 0.133) nociceptive thresholds while showing synergistic to additive effects on mechanical thresholds